This regulation depends on the binding of USP4 to ARF-BP1 through deubiquitination, promoting ARF-BP1-dependent ubiquitination and degradation of p53, which indicates its tumor-promoting role [40]. This evidence concerns the gene CDKN2A and neoplasm.